3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
1035
Neoplasms
813
Carcinoma, Non-Small-Cell Lung
796
Prostatic Neoplasms
617
Colorectal Neoplasms
533
Lung Neoplasms
478
Neoplasm Metastasis
434
Multiple Myeloma
394
Leukemia, Myeloid, Acute
380
Ovarian Neoplasms
333
Pancreatic Neoplasms
316
Melanoma
293
Squamous Cell Carcinoma of Head and Neck
266
Recurrence
260
Carcinoma, Hepatocellular
248
Glioblastoma
237
Brain Neoplasms
236
Triple Negative Breast Neoplasms
213
Head and Neck Neoplasms
210
Carcinoma, Renal Cell
207
Precursor Cell Lymphoblastic Leukemia-Lymphoma
203
Lymphoma
198
Stomach Neoplasms
197
Endometrial Neoplasms
190
Uterine Cervical Neoplasms
182
Lymphoma, Non-Hodgkin
182
Sarcoma
180
Glioma
179
Lymphoma, Large B-Cell, Diffuse
166
Hematologic Neoplasms
162
Interventions
temsirolimus
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Patients With Advanced or Metastatic Solid Tumors
×
90 days
×
Clear all
NCT02215720
2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Completed
45 enrolled